Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|July 2, 2020
<i>In vivo</i> antiviral host response to SARS-CoV-2 by viral load, sex, and ageNicole A P Lieberman, Vikas Peddu, Hong Xie, et al.
Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Mbio|October 21, 2020
Inhibition of Coronavirus Entry <i>In Vitro</i> and <i>Ex Vivo</i> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC DomainVictor K Outlaw, Francesca T Bovier, Megan C Mears, et al.
Mbio|June 1, 2021
Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the BrainCyrille Mathieu, Francesca T Bovier, Marion Ferren, et al.
Vaccine|June 26, 2025
Immunization with full-length TprC variants induces a broad response to surface-exposed epitopes of the Treponema pallidum repeat protein family and is partially protective in the rabbit model of syphilisLorenzo Giacani, Emily Romeis, Austin Haynes, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
<i>Treponema pallidum</i> periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
The Journal of Infectious Diseases|June 27, 2024
Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T CellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.
Neuro-Oncology|November 1, 2020
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNicholas A Vitanza, Matt C Biery, Carrie Myers, et al.
Pageof 5